Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Nivolumab 37pembrolizumab 30cabozantinib 27Specimen Handling 25Magnetic Resonance Spectroscopy 22Ipilimumab 20lenvatinib 16Axitinib 15belzutifan 13CTLA-4 Antigen 10Sunitinib 9Biopsy 9Radiosurgery 8atezolizumab 7Immunoglobulin G 5toripalimab 4fludarabine 4avelumab 4aldesleukin 4Everolimus 4Disulfides 4Cyclophosphamide 4zimberelimab 3tivozanib 3spartalizumab 3pazopanib 3palbociclib 3durvalumab 3cemiplimab 3X-Rays 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Kidney Transplantation × 90 days × Clear all
NCT05725421 2026-05-28

Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy

Case Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡